Literature DB >> 1225484

Leucocytotoxicity in malignant and non-malignant colonic diseases.

B M Vose, M Moore, P F Schofield, I W Dymock.   

Abstract

The survival of cells from five different cultures of allogeneic malignant colonic carcinoma, two from normal adult colonic epithelium and eight from foetal colonic epithelium in the presence of leucocytes from patients with neoplastic and inflammatory disorders of the colon has been compared. Cytotoxicity assessed by the reduction of the number of adherent target cells in microplate wells compared with those surviving in wells treated with tissue culture medium alone was observed with leucocytes from donors in all categories examined including those from individuals without any known abnormality. Patients with ulcerative colitis were the only group to reveal consistent reactivity against cultures derived from all three sources, an observation which may reflect sensitization to organ-related antigens in this disease. In contrast, leucocytes from patients with bowel neoplasia showed reactivity for cells derived from colon carcinoma tissue, which was comparable to that of healthy donors. Evidence for tumour-specific cytotoxicity was therefore lacking in this study. It is suggested that the detection of tumour-associated antigens on cultured cells may be limited by a number of factors of which the wide variation in reactivity among controls and unspecified nature of the target cells are likely to be of greatest importance.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1225484      PMCID: PMC1538437     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  10 in total

1.  Anti-tumour immunoreactivity in colonic carcinoma. A guide to early recognition of recurrence.

Authors:  R C Nairn; A J Rollo; A P Nind; J M Rolland; E P Guli; E A Pihl; D P Stevens
Journal:  Aust N Z J Med       Date:  1974-12

2.  Reactivity of lymphocytes from normal persons on cultured tumor cells.

Authors:  M Takasugi; M R Mickey; P I Terasaki
Journal:  Cancer Res       Date:  1973-11       Impact factor: 12.701

3.  Sequential studies on cell-mediated tumor immunity and blocking serum activity in ten patients with malignant melanoma.

Authors:  I Hellström; G A Warner; K E Hellström; H O Sjögren
Journal:  Int J Cancer       Date:  1973-03-15       Impact factor: 7.396

4.  Cell-mediated and humoral immune reactions to human tumours.

Authors:  R W Baldwin; M J Embleton; J S Jones; M J Langman
Journal:  Int J Cancer       Date:  1973-07-15       Impact factor: 7.396

5.  Cellular immunity in cancer patients against embryonal cells.

Authors:  G Fossati; S Canevari; G Della Porta
Journal:  J Natl Cancer Inst       Date:  1973-08       Impact factor: 13.506

6.  A microassay for cell-mediated immunity.

Authors:  M Takasugi; E Klein
Journal:  Transplantation       Date:  1970-03       Impact factor: 4.939

7.  Cell-mediated cytotoxicity to human pulmonary neoplasms.

Authors:  B M Vose; M Moore; G D Jack
Journal:  Int J Cancer       Date:  1975-02-15       Impact factor: 7.396

8.  Immunological reactivity in patients with carcinoma of colon.

Authors:  R C Nairn; A P Nind; E P Guli; D J Davies; J M Rolland; A R McGiven; E S Hughes
Journal:  Br Med J       Date:  1971-12-18

9.  Effect of lymphocytes from patients with ulcerative colitis on human adult colon epithelial cells.

Authors:  D W Watson; A Quigley; R J Bolt
Journal:  Gastroenterology       Date:  1966-12       Impact factor: 22.682

10.  In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells.

Authors:  P PERLMANN; O BROBERGER
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

  10 in total
  2 in total

1.  Role of autologous lymphocyte cytotoxicity in colonic neoplasia.

Authors:  P Gallagher; B M Vose; M Moore; P F Schofield
Journal:  Gut       Date:  1982-01       Impact factor: 23.059

2.  Specific and non-specific lymphocyte cytotoxicity in colon carcinoma.

Authors:  B M Vose; P Gallagher; M Moore; P F Schofield
Journal:  Br J Cancer       Date:  1981-12       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.